<?xml version="1.0" encoding="ASCII"?>
<biogps><data><item><item key="factor_count">2</item><item key="sample_count">6</item><item key="tags"><item>cancer</item><item>carcinoma</item></item><item key="slug">a-novel-emt-selective-small-molecule-induces-er-st</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-55604</item><item key="id">2073</item><item key="species">human</item><item key="name">A novel EMT-selective small molecule induces ER stress</item></item><item><item key="factor_count">2</item><item key="sample_count">8</item><item key="tags"><item>cancer</item><item>cell</item><item>genome</item><item>lung</item><item>lung cancer</item><item>nsclc</item><item>stem cell</item></item><item key="slug">a-novel-five-gene-signature-predicts-overall-and-r</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-36821</item><item key="id">4450</item><item key="species">human</item><item key="name">A novel five-gene signature predicts overall and recurrence-free survival in NSCLC</item></item><item><item key="factor_count">1</item><item key="sample_count">20</item><item key="tags"><item>cell</item><item>line</item><item>lymphoma</item><item>mantle cell lymphoma</item><item>protein</item></item><item key="slug">a-novel-pro-survival-function-of-cyclin-d1-underli</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-25613</item><item key="id">3879</item><item key="species">human</item><item key="name">A Novel Pro-Survival Function of Cyclin-D1 Underlies Its Oncogenic Role and Potential as a Therapeutic Target in Human and Murine Mantle Cell Lymphoma</item></item><item><item key="factor_count">1</item><item key="sample_count">3</item><item key="tags"><item>bone</item><item>brain</item><item>cell</item><item>chromatin</item><item>disease</item><item>glioblastoma multiforme</item><item>nestin</item><item>neural stem cell</item><item>primary brain tumor</item><item>protein</item><item>scid</item><item>stem cell</item></item><item key="slug">an-rnai-screen-identifies-trrap-as-a-regulator-of</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-27931</item><item key="id">3996</item><item key="species">human</item><item key="name">An RNAi Screen Identifies TRRAP as a Regulator of Brain Tumor-Initiating Cell Differentiation</item></item><item><item key="factor_count">0</item><item key="sample_count">11</item><item key="tags"><item>cell</item><item>epithelial cell</item></item><item key="slug">antagonistic-regulation-of-emt-by-tif1-and-smad4-i</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-28448</item><item key="id">4035</item><item key="species">human</item><item key="name">Antagonistic regulation of EMT by TIF1&#947; and Smad4 in mammary epithelial cells</item></item><item><item key="factor_count">5</item><item key="sample_count">91</item><item key="tags"><item>cancer</item><item>cell</item><item>malaria</item></item><item key="slug">anticancer-properties-of-distinct-antimalaria-drug</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-51739</item><item key="id">2246</item><item key="species">human</item><item key="name">Anticancer properties of distinct antimalaria drug classes</item></item><item><item key="factor_count">1</item><item key="sample_count">9</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>cell</item><item>line</item></item><item key="slug">antisense-mirna-221222-si221222-and-control-inhibi</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-19777</item><item key="id">3544</item><item key="species">human</item><item key="name">Antisense miRNA-221/222 (si221/222) and control inhibitor (GFP) treated fulvestrant-resistant breast cancer cells</item></item><item><item key="factor_count">7</item><item key="sample_count">19</item><item key="tags"><item>cll</item><item>insulin</item><item>protein</item></item><item key="slug">a-pathobiological-role-of-the-insulin-receptor-in</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-26526</item><item key="id">3916</item><item key="species">human</item><item key="name">A Pathobiological Role of the Insulin Receptor in CLL.</item></item><item><item key="factor_count">7</item><item key="sample_count">90</item><item key="tags"><item>cancer</item><item>colon</item><item>colon cancer</item></item><item key="slug">apc-colon-stage-ii</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-26906</item><item key="id">3943</item><item key="species">human</item><item key="name">APC colon stage II</item></item><item><item key="factor_count">5</item><item key="sample_count">8</item><item key="tags"><item>breast</item><item>breast cancer</item><item>cancer</item><item>disease</item><item>hypokalemia</item><item>hypophosphatemia</item><item>median</item><item>rash</item><item>serum</item></item><item key="slug">a-phase-ii-study-of-adding-the-multikinase-sorafen</item><item key="is_default">False</item><item key="geo_gse_id">E-GEOD-40837</item><item key="id">4576</item><item key="species">human</item><item key="name">A phase II study of adding the multikinase sorafenib to existing endocrine therapy in patients with metastatic ER-positive breast cancer.</item></item></data></biogps>
